BRCA1 c.39T>A ;(p.N13K)

Variant ID: 17-41276075-A-T

NM_007294.3(BRCA1):c.39T>A;(p.N13K)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2.

Scientific Reports
Aljarf, Raghad R; Shen, Mengyuan M; Pires, Douglas E V DEV; Ascher, David B DB
Publication Date: 2022-06-21

Variant appearance in text: BRCA1: N13K
PubMed Link: 35729312
Variant Present in the following documents:
  • 41598_2022_13508_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants.

Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Loong, Lucy L; Cubuk, Cankut C; Choi, Subin S; Allen, Sophie S; Torr, Beth B; Garrett, Alice A; Loveday, Chey C; Durkie, Miranda M; Callaway, Alison A; Burghel, George J GJ; Drummond, James J; Robinson, Rachel R; Berry, Ian R IR; Wallace, Andrew A; Eccles, Diana M DM; Tischkowitz, Marc M; Ellard, Sian S; Ware, James S JS; Hanson, Helen H; Turnbull, Clare C; ,
Publication Date: 2022-03

Variant appearance in text: BRCA1: 39T>A; Asn13Lys
PubMed Link: 34906453
Variant Present in the following documents:
  • mmc1.xlsx, sheet 3
View BVdb publication page



Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML.

Npj Breast Cancer
Hart, Steven N SN; Polley, Eric C EC; Shimelis, Hermella H; Yadav, Siddhartha S; Couch, Fergus J FJ
Publication Date: 2020

Variant appearance in text: BRCA1: 39T>A; Asn13Lys
PubMed Link: 32377563
Variant Present in the following documents:
  • 41523_2020_159_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.

Ebiomedicine
Tan, Tuan Zea TZ; Ye, Jieru J; Yee, Chung Vin CV; Lim, Diana D; Ngoi, Natalie Yan Li NYL; Tan, David Shao Peng DSP; Huang, Ruby Yun-Ju RY
Publication Date: 2019-12

Variant appearance in text: BRCA1: 39T>A; N13K
PubMed Link: 31761620
Variant Present in the following documents:
  • mmc1.xlsx, sheet 8
View BVdb publication page



Accurate classification of BRCA1 variants with saturation genome editing.

Nature
Findlay, Gregory M GM; Daza, Riza M RM; Martin, Beth B; Zhang, Melissa D MD; Leith, Anh P AP; Gasperini, Molly M; Janizek, Joseph D JD; Huang, Xingfan X; Starita, Lea M LM; Shendure, Jay J
Publication Date: 2018-10

Variant appearance in text: BRCA1: 39T>A; N13K
PubMed Link: 30209399
Variant Present in the following documents:
  • NIHMS1501643-supplement-2.xlsx, sheet 1
View BVdb publication page



Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.

Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Hart, Steven N SN; Hoskin, Tanya T; Shimelis, Hermela H; Moore, Raymond M RM; Feng, Bingjian B; Thomas, Abigail A; Lindor, Noralane M NM; Polley, Eric C EC; Goldgar, David E DE; Iversen, Edwin E; Monteiro, Alvaro N A ANA; Suman, Vera J VJ; Couch, Fergus J FJ
Publication Date: 2019-01

Variant appearance in text: BRCA1: N13K
PubMed Link: 29884841
Variant Present in the following documents:
  • NIHMS953431-supplement-Table_S2.xls, sheet 1
View BVdb publication page



Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer.

Oncotarget
Wilkerson, Paul M PM; Dedes, Konstantin J KJ; Samartzis, Eleftherios Pierre EP; Dedes, Ioannis I; Lambros, Maryou B MB; Natrajan, Rachael R; Gauthier, Arnaud A; Piscuoglio, Salvatore S; Töpfer, Chantal C; Vukovic, Vesna V; Daley, Frances F; Weigelt, Britta B; Reis-Filho, Jorge S JS
Publication Date: 2017-01-24

Variant appearance in text: BRCA1: 39T>A
PubMed Link: 28002809
Variant Present in the following documents:
  • oncotarget-08-6057-s001.pdf
View BVdb publication page



Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer.

Molecular Cancer Therapeutics
Ihnen, Maike M; zu Eulenburg, Christine C; Kolarova, Teodora T; Qi, Jing Wei JW; Manivong, Kanthinh K; Chalukya, Meenal M; Dering, Judy J; Anderson, Lee L; Ginther, Charles C; Meuter, Alexandra A; Winterhoff, Boris B; Jones, Siân S; Velculescu, Victor E VE; Venkatesan, Natarajan N; Rong, Hong-Mei HM; Dandekar, Sugandha S; Udar, Nitin N; Jänicke, Fritz F; Los, Gerrit G; Slamon, Dennis J DJ; Konecny, Gottfried E GE
Publication Date: 2013-06

Variant appearance in text: BRCA1: 39T>A; N13K
PubMed Link: 23729402
Variant Present in the following documents:
  • Main text
View BVdb publication page